Table 4. Computationally predicted minimal perturbations sets (MIS) required for transitioning TEM regulatory network into highly or weakly pro-angiogenic TEM.
RTK activity inhibited | Up-regulated Inflammatory Ligand | Up-regulated VEGFR-1 ligand | Up-regulated TIE-2 ligand | ||
---|---|---|---|---|---|
Transition to weakly pro-angiogenic TEM | |||||
Group 1 | |||||
TIE-2 | TGF-β | VEGF | - | ||
TIE-2 | TGF-β | PlGF | - | ||
TIE-2 | TGF-β | - | ANG-1 | ||
TIE-2 | TGF-β | - | ANG-2 | ||
Group 2 | |||||
VEGFR-1 | TNF-α | - | ANG-1 | ||
VEGFR-1 | TNF-α | VEGF | - | ||
VEGFR-1 | - | all but PlGF | - | ||
TIE-2 and VEGFR-1 | - | - | - | ||
Group 3 | |||||
- | TNF-α and TGF-β | PlGF | - | ||
- | TNF-α and TGF-β | - | ANG-1 | ||
- | TNF-α and TGF-β | VEGF | - | ||
Transition to highly pro-angiogenic TEM | - | TNF-α | PlGF | ANG-2 |
These two final desired cell steady states were obtained by assigning to TIE-2 and VEGFR-1 nodes a fixed polarity of either both high (highly pro-angiogenic i.e tumor TEM) or low (weakly proangiogenic i.e. blood TEM) expression levels. Computationally predicted MIS decreasing TEM pro-angiogenic activity were classified in three groups based on the receptor tyrosine kinase (RTK) inhibited and inflammatory (TGF-β or TNF-α) and angiogenic ligands up-regulated.